Morniflumate is a non-steroidal anti-inflammatory drug (NSAID) derived from niflumic acid, indicated for the symptomatic management of inflammatory conditions affecting the airways, ear, nose, and throat… Read more
Morniflumate is a non-steroidal anti-inflammatory drug (NSAID) derived from niflumic acid, indicated for the symptomatic management of inflammatory conditions affecting the airways, ear, nose, and throat (ENT) regions, as well as the urogenital and osteoarticular systems. This category provides access to essential pharmaceutical reference standards for Morniflumate API, including related process impurities such as 2-morpholinoethyl 6-((3-(trifluoromethyl)phenyl)amino)nicotinate and potential degradation products like N-nitroso Morniflumate. Pharmaceutical laboratories utilize these high-quality compounds for comprehensive impurity profiling, method validation, and rigorous quality control testing. By incorporating these materials into analytical workflows, researchers can ensure compliance with regulatory standards, accurately identify unknown peaks during stability studies, and maintain the precision required for routine potency and safety assessments of this therapeutic agent.